Anales de la RANM

214 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 TRASPLANTE DE HÍGADO An RANM. 2026;143(02): 207 - 215 Jiménez Romero C, et al. 10. Jiménez Romero C, Caso Maestro O, Marca- cuzco Quinto A, et al. Donantes hepáticos con criterios ampliados. Capítulo 7. En: Moreno González E, Jiménez Romero C, García Sesma A. Trasplantes.1ª Edición. Madrid: Panameri- cana; 2025. p. 95-101. 11. Feng S, Goodrich NP, Bragg-Gresham, et al. Characteristics associated with liver failure: the concept of a donor risk index. Am J Trans- plant 2006;6:783-790. 12. Dosier del Registro Español de Trasplante He- pático (ONT). (Disponible en :http:77www.ont . es). 13. Jiménez-Romero C, Clemares-Lama M, Manri- que-Municio A, et al. Long-term results using old liver grafts for transplantation: sexagena- rian versus liver donors older than 70 years. World J Surg 2013;37:2211-2221. 14. Ghinolfi D, Marti J, De Simone P, et al. Use of octogenarian donors for liver transplantation. Am J Transplant 2014;14:2062-2071. 15. Jiménez Romero C, Cambra F, Caso O, et al. Octogenarian liver grafts: is their use for transplant currently justified? World J Gas- troenterol 2017;23:3099-3110. 16. Caso Maestro O, Justo Alonso I, Marcacuz- co Quinto A, et al. Expanding donor age in liver transplantation using liver grafts from nonagenarian donors. Clin Transplant 2022;36:e14684. 17. Haugen CE, Thomas AG, Garonzik-Wang J, et al. Minimizing risks associated with older liver donors by matching to preferred recipients: a national registry and validation study. Trans- plantation 2018;102:1514-1519. 18. Berenguer M, López-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepa- tol 2001;35:666-678. 19. Jiménez-Romero C, Justo I, Marcacuzco A, et al. Safe use of livers from deceased donors older than 70 years in recipients with HCV cirrhosis treated with direct-action antivi- rals. Retrospective cohort study. Int J Surg 2021;91:105981. 20. Registro Español de Trasplante Hepático (RETH). Memoria General de Resultados Año 2024. 21. Jiménez-Romero C, Manrique A, Calvo J, et al. Liver transplantation using uncontro- lled donors after circulatory death: a 10-year single-center experience. Transplantation 2019;103:2497-2505. 22. Molina M, Guerrero-Ramos F, Fernández-Ruiz M, et al. Kidney transplant from uncontrolled donation after circulatory death donors main- tained by nECMO has long-term outcomes comparable to standard criteria donation after brain death. Am J Transplant 2019;19:434-447. 23. Caso-Maestro O, Jiménez-Romero C, Justo- Alonso I, et al. Analyzing predictors of graft survival in patients undergoing liver trans- plantation with donors aged 70 years and over. World J Gastroenterol 2018;24:6391-5402. 24. Jiménez-Romero C, Vivas-López A, Mar- cacuzco A, Caso O, Bernaldo de Quiros M, Justo-Alonso I. Risk factors of adult recipient survival beyond 20 years since liver transplan- tation: retrospective cohort study. Hepatol Int 2026;20:408-418. 25. Ojo AO. Renal disease in recipients of non- renal solid organ transplantation. Semin Ne- phrol 2007;27:498-507. 26. Rodríguez-Perálvarez M, Germani G, Darius T, Lerut J, Tsochatzis E, Burroughs AK. Tacro- limus through levels, rejection and renal im- pairment in liver transplantation. A systema- tic review and meta-analysis. Am J Transplant 2012;12:2797-2814. 27. Carenco C, Assenat E, Faure S, et al. Tacro- limus and the risk of solid cancers after liver transplant: a dose effect relationship. Am J Transplant 2015;15:678-686. 28. Biolato M, Pedicino D. Major adverse cardio- vascular events after liver transplantation: call for a shared definition. Abstract Sesions. 2026 ILTS Congress. Mayo 6-9. Ginebra (Suiza). 29. Duffy JP, Kao K, Ko CY, et al. Long-term pa- tient outcome and quality of life after liver transplantation. Analysis of 20-year survivors. Ann Surg 2010; 252:652-661. 30. Jiménez-Romero C, Justo-Alonso I, Cambra- Molero F, et al. Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis. World J Hepatol 2015;7:942-953. 31. San Juan Garrido R, Fortún Abete J, Montejo Baranda M, Varo Pérez E. Trasplante hepático. Capítulo 24. En: Aguado García. Infecciones en pacientes trasplantados. 3ª edición. Barce- lona: Elsevier; 2009. p. 473-498. 32. Daniel KE, Eickhoff J, Lucey MR. Why do pa- tients die after a liver transplantation? Clin Transpl 2017;31:e12906. 33. Rana A, Ackah RL, Webb GJ, et al. No gains in long-term survival after liver transplan- tation over the past three decades. Ann Surg 2019;269:20-27. 34. Adam R, Karam V, Delvart V, et al. Evolution of indications and results of liver transplanta- tion in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol 2012;57:675-688. 35. Jain A, Singhal A, Fontes P, et al. One thousand consecutive primary liver transplants under tacrolimus immunosuppression: a 17-to 20- year longitudinal follow-up. Transplantation 2011;91:1025-1030. 36. De Luca L, Kalafateli M, Bianchi S, et al. Car- diovascular morbidity is increased post-liver transplantation even in recipients with no pre- existing risk factors. Liver Int 2019;39:1557- 1565. 37. Van der Heide F, Dijkstra G, Porte RJ, Klei- beuker JH, Haagsma EB. Smoking behavior in liver transplant recipients. Liver Transpl 2009;15:648-655. 38. Collet D, Mumford L, Banner NR, Neuberger J, Watson C. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry Audit. Am J Transplant 2010;10:1889-1896. 39. Aberg E, Isoniem H, Hockerstedt K. Long- term results of liver transplantation. Scand J Surg 2011;100:14-21.